文献速递免疫规划妇幼与学校卫生

棉鼠模型中母体接种呼吸道合胞病毒(RSV)疫苗安全性的临床前评估

Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats.
PubMed 文献 · Vaccine · 2017-06-16

本研究在棉鼠中建立母体RSV疫苗接种模型,检验已知不安全FI-RSV Lot 100疫苗在被动转移母体免疫存在时是否诱导疫苗增强性疾病,以及该疫苗接种RSV致敏母鼠是否对母鼠或幼崽构成健康风险。结果显示幼崽FI-RSV免疫后RSV感染诱导疫苗增强性疾病,与母鼠RSV血清状态无关;RSV血清阳性母鼠接种FI-RSV对母鼠和婴儿均无健康风险。研究还提出活RSV肌内接种等“安全”疫苗可能在血清阳性母鼠所生RSV感染幼崽中诱导疫苗增强性疾病,并首次描述免疫血清阳性棉鼠分娩时RSV中和抗体滴度急剧下降。

要点

  • 幼崽FI-RSV免疫后RSV感染诱导疫苗增强性疾病,与母鼠RSV血清状态无关。
  • RSV血清阳性母鼠接种FI-RSV对母鼠和婴儿均未显示健康风险。
  • 活RSV肌内接种等“安全”疫苗可能在血清阳性母鼠所生RSV感染幼崽中诱导疫苗增强性疾病。

核心结论

  • 幼崽FI-RSV免疫后RSV感染诱导疫苗增强性疾病,与母鼠RSV血清阳性或阴性无关。
  • RSV血清阳性母鼠接种FI-RSV对母鼠和婴儿均不构成健康风险。
  • “安全”RSV疫苗(如活RSV肌内接种)可能在血清阳性母鼠所生RSV感染幼崽中诱导疫苗增强性疾病。
  • 免疫血清阳性棉鼠分娩时RSV中和抗体滴度急剧下降,可能反映母体免疫抑制。

研究设计与样本

  • 在棉鼠中建立母体RSV疫苗接种模型,检验FI-RSV Lot 100疫苗在被动转移母体免疫存在时及RSV致敏母鼠接种后的安全性。

主要发现

  • 幼崽FI-RSV免疫后RSV感染诱导疫苗增强性疾病,与母鼠RSV血清状态无关。
  • RSV血清阳性母鼠接种FI-RSV对母鼠和婴儿均无健康风险。
  • 活RSV肌内接种等“安全”疫苗可能在血清阳性母鼠所生RSV感染幼崽中诱导疫苗增强性疾病。
  • 免疫血清阳性棉鼠分娩时RSV中和抗体滴度急剧下降。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Maternal immunization directed to control RSV infection in newborns and infants is an appealing vaccination strategy currently under development. In this work we have modeled maternal vaccination against RSV in cotton rats (CR) to answer two fundamental questions on maternal vaccine safety. We tested (i), whether a known, unsafe RSV vaccine (i.e., FI-RSV Lot 100 vaccine) induces vaccine enhanced disease in the presence of passively transferred, RSV maternal immunity, and (ii) whether the same FI-RSV vaccine could induce vaccine enhanced disease in CR litters when used to immunize their RSV-primed mothers. Our data show that FI-RSV immunization of pups with subsequent RSV infection results in vaccine-enhanced disease independent of whether the pups were born to RSV-seropositive or RSV-seronegative mothers, and that FI-RSV immunization of RSV-seropositive mothers does not present a health risk to either the mother or the infant. Our study also raises a novel concern regarding infant immunization, namely that "safe" RSV vaccines (e.g., live RSV administered intramuscularly) may induce vaccine-enhanced disease in RSV-infected pups born to seropositive mothers. Finally, we describe for the first time a sharp decrease in RSV neutralizing antibody titers in immunized seropositive CR at the time of delivery. This decline may reflect maternal immune suppression, potentially pinpointing a window of increased vulnerability to RSV infection that could be alleviated by effective immunization of expectant mothers.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Blanco JCG, Pletneva LM, Otoa RO, et al. Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats. Vaccine. 2017. PMID: 28624306. doi:10.1016/j.vaccine.2017.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。